Moxifloxacin vs. Polytrim for Conjunctivitis

University of Rochester

Status and phase: Completed; Phase 4

Conditions: Conjunctivitis

Treatments: Drug: polytrim; Drug: moxifloxacin

Study type: Interventional

Funder types: Other

Identifiers

NCT00581542

RSRB #17454

Details and patient eligibility

About

The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications are approved by the Food and Drug Administration, for treatment of conjunctivitis. This study will investigate if both of the medications are equally good.

Enrollment: 124 patients

Sex: All

Ages: 1 to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 1 - 18 years of age with presumed bacterial conjunctivitis.

Exclusion criteria

• Previous antibiotics or to receive systemic antibiotic.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

124 participants in 2 patient groups

Moxifloxacin Opthalmic solution

Active Comparator group

Treatment:

Drug: polytrim

Polymyxin B-trimethoprim opthalmic solution

Active Comparator group

Treatment:

Drug: moxifloxacin